Moleculin Reports First Quarter 2023 Financial Results
Go back to Moleculin Reports First Quarter 2023 Financial Results| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 2.40 -0.24 (9.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.64 | 52 Week High | $9.58 | |||
| Open | $2.59 | 52 Week Low | $2.34 | |||
| Day High | $2.65 | P/E | N/A | |||
| Day Low | $2.38 | EPS | $-0.34 | |||
| Volume | 406,347 | |||||

